FDA Inspection
Lonza Guangzhou Pharmaceutical Ltd.Lonza Guangzhou Pharmaceutical Ltd. – FDA Inspection, Aug 23, 2013
Record Details
This FDA Inspection record concerns Lonza Guangzhou Pharmaceutical Ltd., with an inspection on August 23, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 23, 2013
- Product Type
- Drugs
View Company Profile
ID · 6173e794-a20c-4232-b5fe-2d603c6d7df3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 846043
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Lonza Guangzhou Pharmaceutical Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2025 | Not classified | Office of Inspections and Investigations | |
| December 14, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Guangzhou Pharmaceutical Ltd.
- FDA Inspection 1292806 - 2025-10-31
- FDA Inspection 1077023 - 2018-12-14
- FDA Inspection 981011 - 2016-08-19
- FDA Inspection 709669 - 2010-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.